Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on McKesson (MCK – Research Report), Biogen (BIIB – ...

Riot also announced it has hired investment banks Evercore and Northland Capital Markets to lead discussions with potential ...

Canada Goose (NYSE:GOOS – Get Free Report) had its price objective dropped by investment analysts at Evercore ISI from $13.00 ...

Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Fintel reports that on February 11, 2025, Evercore ISI Group upgraded their outlook for TXNM Energy (NYSE:TXNM) from In-Line ...

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Acadian Asset Management (AAMI – Research ...

Riot Platforms is expanding into AI and high-performance computing partnerships while adding three new board members with ...